Remarkably, treatment with FXR agonists ameliorated DKD in different mice models of diabetic nephropathy including db/db mice with type 2 diabetes [141]; DBA/2J mice fed a high-fat, high-cholesterol diet [12]; and STZ-induced type 1 diabetic DBA/2J mice [143]. Here, NR1H4 is linked to diabetic kidney disease.